Application of Benchtop NMR for Metabolomics Study Using Feces of Mice with DSS-Induced Colitis

Nuclear magnetic resonance (NMR)-based metabolomics, which comprehensively measures metabolites in biological systems and investigates their response to various perturbations, is widely used in research to identify biomarkers and investigate the pathogenesis of underlying diseases. However, further applications of high-field superconducting NMR for medical purposes and field research are restricted by its high cost and low accessibility. In this study, we applied a low-field, benchtop NMR spectrometer (60 MHz) employing a permanent magnet to characterize the alterations in the metabolic profile of fecal extracts obtained from dextran sodium sulfate (DSS)-induced ulcerative colitis model mice and compared them with the data acquired from high-field NMR (800 MHz). Nineteen metabolites were assigned to the 60 MHz 1H NMR spectra. Non-targeted multivariate analysis successfully discriminated the DSS-induced group from the healthy control group and showed high comparability with high-field NMR. In addition, the concentration of acetate, identified as a metabolite with characteristic behavior, could be accurately quantified using a generalized Lorentzian curve fitting method based on the 60 MHz NMR spectra.

[1]  Jana M. Braunger,et al.  Metabolomic profiles predict individual multidisease outcomes , 2022, Nature Medicine.

[2]  S. Kuhn,et al.  Computational Simulation of 1 H NMR Profiles of Complex Biofluid Analyte Mixtures at Differential Operating Frequencies: Applications to Low-Field Benchtop Spectra. , 2021, Magnetic resonance in chemistry : MRC.

[3]  J. L. Izquierdo-García,et al.  Benchtop nuclear magnetic resonance-based metabolomic approach for the diagnosis of bovine tuberculosis. , 2021, Transboundary and emerging diseases.

[4]  D. Holland,et al.  Quantitative analysis of wine and other fermented beverages with benchtop NMR. , 2021, Analytica chimica acta.

[5]  R. Brüschweiler,et al.  DEEP picker is a deep neural network for accurate deconvolution of complex two-dimensional NMR spectra , 2021, Nature Communications.

[6]  M. Spraul,et al.  Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome , 2021, Journal of proteome research.

[7]  P. Lakatos,et al.  The burden of inflammatory bowel disease in Europe in 2020. , 2021, Journal of Crohn's & colitis.

[8]  K. Clément,et al.  Gut microbiota-derived metabolites as central regulators in metabolic disorders , 2020, Gut.

[9]  J. L. Izquierdo-García,et al.  Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker , 2020, Scientific Reports.

[10]  M. Grootveld,et al.  Low-Field Benchtop NMR Spectroscopy as a Potential Non-Stationary Tool for Point-of-Care Urinary Metabolite Tracking in Diabetic Conditions. , 2020, Diabetes research and clinical practice.

[11]  E. von Harbou,et al.  Bayesian approach for automated quantitative analysis of benchtop NMR data. , 2020, Journal of magnetic resonance.

[12]  S. Engelsen,et al.  Human faecal 1H-NMR metabolomics: Evaluation of solvent and sample processing on coverage and reproducibility of signature metabolites. , 2020, Analytical chemistry.

[13]  F. Casanova,et al.  Benchtop Low-Frequency 60 MHz NMR Analysis of Urine: A Comparative Metabolomics Investigation , 2020, Metabolites.

[14]  T. Aizawa,et al.  Disease progression-associated alterations in fecal metabolites in SAMP1/YitFc mice, a Crohn’s disease model , 2020, Metabolomics.

[15]  H. Sokol,et al.  Gut microbiota-derived metabolites as key actors in inflammatory bowel disease , 2020, Nature Reviews Gastroenterology & Hepatology.

[16]  C. Cobas.  NMR signal processing, prediction, and structure verification with machine learning techniques , 2020, Magnetic resonance in chemistry : MRC.

[17]  L. Tenori,et al.  Uniqueness of the NMR approach to metabolomics , 2019, TrAC Trends in Analytical Chemistry.

[18]  T. H. Nguyen,et al.  The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2019, The lancet. Gastroenterology & hepatology.

[19]  Q. Liao,et al.  A holistic view of gallic acid-induced attenuation in colitis based on microbiome-metabolomics analysis. , 2019, Food & function.

[20]  D. Wishart,et al.  NMR Spectroscopy for Metabolomics Research , 2019, Metabolites.

[21]  Matthew B. Scholz,et al.  Multi-Omic Analysis of the Microbiome and Metabolome in Healthy Subjects Reveals Microbiome-Dependent Relationships Between Diet and Metabolites , 2019, Front. Genet..

[22]  Colin J. Brislawn,et al.  Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases , 2019, Nature.

[23]  K. Faber,et al.  Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases , 2019, Front. Immunol..

[24]  F. Casanova,et al.  Progress in low-field benchtop NMR spectroscopy in chemical and biochemical analysis. , 2019, Analytica chimica acta.

[25]  Olivier Gonçalves,et al.  Benchtop NMR for the monitoring of bioprocesses , 2019, Magnetic resonance in chemistry : MRC.

[26]  Y. Shao,et al.  Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease , 2019, Molecular Neurodegeneration.

[27]  C. Huttenhower,et al.  Gut microbiome structure and metabolic activity in inflammatory bowel disease , 2018, Nature Microbiology.

[28]  F. Casanova,et al.  Low-Field, Benchtop NMR Spectroscopy as a Potential Tool for Point-of-Care Diagnostics of Metabolic Conditions: Validation, Protocols and Computational Models , 2018, High-throughput.

[29]  B. Blümich,et al.  Desktop NMR and Its Applications From Materials Science To Organic Chemistry. , 2018, Angewandte Chemie.

[30]  B. Blümich,et al.  Compact low-field NMR spectroscopy and chemometrics: A tool box for quality control of raw rubber , 2018 .

[31]  G. Remaud,et al.  High-throughput authentication of edible oils with benchtop Ultrafast 2D NMR. , 2018, Food chemistry.

[32]  S. Tsuneda,et al.  Meta-Analysis of Fecal Microbiota and Metabolites in Experimental Colitic Mice during the Inflammatory and Healing Phases , 2017, Nutrients.

[33]  K. Kharbanda,et al.  Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis , 2017, World journal of gastroenterology.

[34]  R. Gerszten,et al.  The Emerging Role of Metabolomics in the Diagnosis and Prognosis of Cardiovascular Disease. , 2016, Journal of the American College of Cardiology.

[35]  N. Leadbeater,et al.  A benchtop NMR spectrometer as a tool for monitoring mesoscale continuous-flow organic synthesis: equipment interface and assessment in four organic transformations , 2016 .

[36]  Caroline H. Johnson,et al.  Metabolomics: beyond biomarkers and towards mechanisms , 2016, Nature Reviews Molecular Cell Biology.

[37]  Wei Jia,et al.  Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics , 2016, International journal of molecular sciences.

[38]  Ian D Wilson,et al.  An overview of fecal sample preparation for global metabolic profiling. , 2015, Journal of pharmaceutical and biomedical analysis.

[39]  Harry J. Flint,et al.  The gut microbiota, bacterial metabolites and colorectal cancer , 2014, Nature Reviews Microbiology.

[40]  U. Günther,et al.  Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn’s disease and healthy individuals , 2014, Metabolomics.

[41]  Bernhard Blümich,et al.  Miniaturization of NMR systems: desktop spectrometers, microcoil spectroscopy, and "NMR on a chip" for chemistry, biochemistry, and industry. , 2014, Chemical reviews.

[42]  J. Paul,et al.  Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India. , 2013, World journal of gastroenterology.

[43]  Timothy L. Tickle,et al.  Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment , 2012, Genome Biology.

[44]  Hans J. Vogel,et al.  Quantitative Metabolomic Profiling of Serum, Plasma, and Urine by 1H NMR Spectroscopy Discriminates between Patients with Inflammatory Bowel Disease and Healthy Individuals , 2012, Journal of proteome research.

[45]  T. Azuma,et al.  GCMS‐based metabolomic study in mice with colitis induced by dextran sulfate sodium , 2011, Inflammatory bowel diseases.

[46]  G. Kollias,et al.  Metabolic phenotyping of the Crohn's disease-like IBD etiopathology in the TNF(ΔARE/WT) mouse model. , 2011, Journal of proteome research.

[47]  E. K. Kemsley,et al.  Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. , 2011, Journal of proteome research.

[48]  T. Takenawa,et al.  GC/MS-based profiling of amino acids and TCA cycle-related molecules in ulcerative colitis , 2011, Inflammation Research.

[49]  H. Vogel,et al.  Quantitative metabolomic profiling of serum and urine in DSS-induced ulcerative colitis of mice by (1)H NMR spectroscopy. , 2010, Journal of proteome research.

[50]  G. Hwang,et al.  1H NMR-based metabonomic assessment of probiotic effects in a colitis mouse model , 2010, Archives of pharmacal research.

[51]  A. Abdulamir,et al.  The Impact of the Level of the Intestinal Short Chain Fatty Acids in Inflammatory Bowel Disease Patients Versus Healthy Subjects , 2010, The open biochemistry journal.

[52]  J. Jansson,et al.  Metabolomics Reveals Metabolic Biomarkers of Crohn's Disease , 2009, PloS one.

[53]  Dirk Haller,et al.  Metabolic assessment of gradual development of moderate experimental colitis in IL-10 deficient mice. , 2009, Journal of proteome research.

[54]  U. Sharma,et al.  Metabolism of the colonic mucosa in patients with inflammatory bowel diseases: an in vitro proton magnetic resonance spectroscopy study. , 2009, Magnetic resonance imaging.

[55]  H. Ogata,et al.  Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. , 2008, International journal of medical microbiology : IJMM.

[56]  T. Ebbels,et al.  Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts , 2007, Nature Protocols.

[57]  M. Neurath,et al.  Mouse models of inflammatory bowel disease. , 2007, Advanced drug delivery reviews.

[58]  I. Wilson,et al.  Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. , 2007, Journal of proteome research.

[59]  Ray L Somorjai,et al.  The use of 1H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease , 2001, American Journal of Gastroenterology.